Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache

Annals of Neurology

Volumn 79, Issue 6, 2016, Pages 1000-1013

  Perry, Carlton J ^a   Blake, Pamela ^b   Buettner, Catherine ^c,d   Papavassiliou, Efstathios ^c,d   Schain, Aaron J ^c,d   Bhasin, Manoj K ^c,d   Burstein, Rami ^c,d  

^a River Oaks Plastic Surgery Center   (United States)

^b Headache Center of Greater Heights   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10 RECEPTOR ALPHA; LEVODOPA; MONOCYTE CHEMOTACTIC PROTEIN 2; TOLL LIKE RECEPTOR 2; BIOLOGICAL MARKER; CEFALORIDINE; CLEC4D PROTEIN, HUMAN; I KAPPA B KINASE ALPHA; IL1R2 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE II; ISOFLURANE; LECTIN; TNFAIP3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3;

ADOLESCENT; ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEADACHE; HUMAN; HUMAN TISSUE; K NEAREST NEIGHBOR; LEUKOCYTE; MACROPHAGE ACTIVATION; MALE; PATHOPHYSIOLOGY; PATIENT HEALTH QUESTIONNAIRE 9; PERIOSTEUM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; TRANSFORMED MIGRAINE; UPREGULATION; AGED; CASE CONTROL STUDY; CHRONIC DISEASE; DIET RESTRICTION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; MIGRAINE; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CASE-CONTROL STUDIES; CEPHALORIDINE; CHRONIC DISEASE; FASTING; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; ISOFLURANE; LECTINS, C-TYPE; LEVODOPA; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NF-KAPPAB INHIBITOR ALPHA; PERIOSTEUM; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-1 TYPE II; TUMOR NECROSIS FACTOR ALPHA-INDUCED PROTEIN 3; YOUNG ADULT;

EID: 84965151806     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24665     Document Type: Article

References (88)

1. Scher AI, Stewart WF, Ricci JA, Lipton RB,. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003; 106: 81-89.
2. Castillo J, Munoz P, Guitera V, Pascual J,. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1999; 39: 190-196.
3. Silberstein S, Olesen J,. Chronic migraine. In:, Olesen J, Goadsby P, Ramadan N, et al, eds. The headaches. Philadelphia, PA: Lippincott Williams & Wilkins, 2006: 613-619.
4. Jensen R, Becker WJ,. Symptomatology of chronic tension-type headaches. In:, Olesen J, Goadsby P, Ramadan N, et al, eds. The headaches. Philadelphia, PA: Lippincott Williams & Wilkins, 2006: 693-699.
5. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
6. Maniyar FH, Sprenger T, Monteith T, et al., Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 2014; 137 (pt 1): 232-241.
7. Pietrobon D, Moskowitz MA,. Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations. Nat Rev Neurosci 2014; 15: 379-393.
8. Burstein R,. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001; 89: 107-110.
9. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P,. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 2009; 8: 679-690.
10. Sprenger T, Borsook D,. Migraine changes the brain: neuroimaging makes its mark. Curr Opin Neurol 2012; 25: 252-262.
11. Bendtsen L,. Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 2000; 20: 486-508.
12. Karatas H, Erdener SE, Gursoy-Ozdemir Y, et al., Spreading depression triggers headache by activating neuronal Panx1 channels. Science 2013; 339: 1092-1095.
13. Jensen R, Rasmussen BK, Pedersen B, et al., Cephalic muscle tenderness and pressure pain threshold in a general population. Pain 1992; 48: 197-203.
14. Jensen R, Rasmussen BK, Pedersen B, Olesen J,. Muscle tenderness and pressure pain thresholds in headache. A population study. Pain 1993; 52: 193-199.
15. Tfelt-Hansen P, Lous I, Olesen J,. Prevalence and significance of muscle tenderness during common migraine attacks. Headache 1981; 21: 49-54.
16. Selby G, Lance JW,. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960; 23: 23-32.
17. Aaseth K, Grande RB, Lundqvist C, Russell MB,. Pericranial tenderness in chronic tension-type headache: the Akershus population-based study of chronic headache. J Headache Pain 2014; 15: 58.
18. Iversen HK, Langemark M, Andersson PG, et al., Clinical characteristics of migraine and episodic tension-type headache in relation to old and new diagnostic criteria. Headache 1990; 30: 514-519.
19. Langemark M, Olesen J, Poulsen DL, Bech P,. Clinical characterization of patients with chronic tension headache. Headache 1988; 28: 590-596.
20. Jakubowski M, McAllister PJ, Bajwa ZH, et al., Exploding vs. imploding headache in migraine prophylaxis with botulinum toxin A. Pain 2006; 125: 286-295.
21. Snow V, Weiss K, Wall EM, Mottur-Pilson C,. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002; 137: 840-849.
22. Tfelt-Hansen P,. Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment. Headache 2008; 48: 601-605.
23. Scher AI, Lipton RB, Stewart WF, Bigal M,. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 2010; 30: 321-328.
24. Bigal ME, Serrano D, Buse D, et al., Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48: 1157-1168.
25. Widlus DM,. Calcific tendonitis of the longus colli muscle: a cause of atraumatic neck pain. Ann Emerg Med 1985; 14: 1014-1017.
26. Coebergh JA, Koppen H, van Gils AP, de Bruijn BF,. Neck pain due to tendonitis of the longus colli muscle [in Dutch]. Ned Tijdschr Geneeskd 2010; 154: A933.
27. Gentleman RC, Carey VJ, Bates DM, et al., Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
28. Angin M, Sharma S, King M, et al., HIV-1 infection impairs regulatory T-cell suppressive capacity on a per-cell basis. J. Infect Dis 2014; 210: 899-903.
29. Yeung KY, Ruzzo WL,. Principal component analysis for clustering gene expression data. Bioinformatics 2001; 17: 763-774.
30. Smyth GK,. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.
31. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57: 289-300.
32. Huang DW, Sherman BT, Tan Q, et al., DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007; 35 (Web Server issue): W169-W175.
33. Fisher R,. On the interpretation of x2 from contingency tables, and the calculation of P. J R Stat Soc 1922; 85 (7).
34. Rajamani D, Singh PK, Rottmann BG, et al., Temporal retinal transcriptome and systems biology analysis identifies key pathways and hub genes in Staphylococcus aureus endophthalmitis. Sci Rep 2016; 6: 21502.
35. Bhasin M, Huang Z, Pradhan-Nabzdyk L, et al., Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury. PLoS One 2012; 7: e39123.
36. Zhang L, Bhasin M, Schor-Bardach R, et al., Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression. PLoS One 2011; 6: e19144.
37. Damrauer SM, Studer P, da Silva CG, et al., A20 modulates lipid metabolism and energy production to promote liver regeneration. PLoS One 2011; 6: e17715.
38. Koulmanda M, Bhasin M, Hoffman L, et al., Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A 2008; 105: 16242-16247.
39. Ueda Y, Tokashiki S, Kanemaru A, Kojima T,. Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease. Biochem Biophys Res Commun 2012; 428: 401-404.
40. Rampil IJ, Moller DH, Bell AH,. Isoflurane modulates genomic expression in rat amygdala. Anesth Analg 2006; 102: 1431-1438.
41. Rokushima M, Fujisawa K, Furukawa N, et al., Transcriptomic analysis of nephrotoxicity induced by cephaloridine, a representative cephalosporin antibiotic. Chem Res Toxicol 2008; 21: 1186-1196.
42. Hakvoort TB, Moerland PD, Frijters R, et al., Interorgan coordination of the murine adaptive response to fasting. J Biol Chem 2011; 286: 16332-16343.
43. Proost P, Wuyts A, Van Damme J,. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol 1996; 59: 67-74.
44. Gong W, Howard OM, Turpin JA, et al., Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J Biol Chem 1998; 273: 4289-4292.
45. Heinrich PC, Behrmann I, Haan S, et al., Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374 (pt 1): 1-20.
46. Verma IM, Stevenson JK, Schwarz EM, et al., Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995; 9: 2723-2735.
47. Nakamura H, Mizuno T, Kawamura K, Kamino T,. CSF enzyme activities in patients with head injury-especially on GOT, GPT, LDH, and CPK [in Japanese]. No Shinkei Geka 1976; 4: 753-762.
48. Hu X, Chen J, Wang L, Ivashkiv LB,. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol 2007; 82: 237-243.
49. Williams LM, Ricchetti G, Sarma U, et al., Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology 2004; 113: 281-292.
50. Meyaard L,. Leukocyte associated Ig-like receptor (LAIR). J Biol Regul Homeost Agents 2003; 17: 330-333.
51. Kosaras B, Jakubowski M, Kainz V, Burstein R,. Sensory innervation of the calvarial bones of the mouse. J Comp Neurol 2009; 515: 331-348.
52. Zhao J, Levy D,. The sensory innervation of the calvarial periosteum is nociceptive and contributes to headache-like behavior. Pain 2014; 155: 1392-1400.
53. Lous I, Olesen J,. Evaluation of pericranial tenderness and oral function in patients with common migraine, muscle contraction headache and 'combination headache '. Pain 1982; 12: 385-393.
54. Bartsch T, Goadsby PJ,. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain 2003; 126 (pt 8): 1801-1813.
55. Burstein R, Yarnitsky D, Goor-Aryeh I, et al., An association between migraine and cutaneous allodynia. Ann Neurol 2000; 47: 614-624.
56. Schueler M, Messlinger K, Dux M, et al., Extracranial projections of meningeal afferents and their impact on meningeal nociception and headache. Pain 2013; 154: 1622-1631.
57. Schueler M, Neuhuber WL, De Col R, Messlinger K,. Innervation of rat and human dura mater and pericranial tissues in the parieto-temporal region by meningeal afferents. Headache 2014; 54: 996-1009.
58. Naka T, Nishimoto N, Kishimoto T,. The paradigm of IL-6: from basic science to medicine. Arthritis Res 2002; 4 (suppl 3): S233-S242.
59. Erta M, Quintana A, Hidalgo J,. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 2012; 8: 1254-1266.
60. Heinrich PC, Behrmann I, Muller-Newen G, et al., Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998; 334 (pt 2): 297-314.
61. Bob P, Raboch J, Maes M, et al., Depression, traumatic stress and interleukin-6. J Affect Disord 2010; 120: 231-234.
62. Dethlefsen C, Hojfeldt G, Hojman P,. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat 2013; 138: 657-664.
63. Guo Y, Xu F, Lu T, et al., Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 2012; 38: 904-910.
64. Senn JJ, Klover PJ, Nowak IA, Mooney RA,. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002; 51: 3391-3399.
65. Tackey E, Lipsky PE, Illei GG,. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus 2004; 13: 339-343.
66. Yan J, Melemedjian OK, Price TJ, Dussor G,. Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain 2012; 8: 6.
67. Zhang X, Burstein R, Levy D,. Local action of the proinflammatory cytokines IL-1beta and IL-6 on intracranial meningeal nociceptors. Cephalalgia 2012; 32: 66-72.
68. Borrello S, Nicolo C, Delogu G, et al., TLR2: a crossroads between infections and autoimmunity? Int J Immunopathol Pharmacol 2011; 24: 549-556.
69. Tang SC, Arumugam TV, Xu X, et al., Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 2007; 104: 13798-13803.
70. Zhang G, Ghosh S,. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107: 13-19.
71. Kawai T, Akira S,. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13: 460-469.
72. Akira S, Takeda K,. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
73. Hoffmann O, Braun JS, Becker D, et al., TLR2 mediates neuroinflammation and neuronal damage. J Immunol 2007; 178: 6476-6481.
74. Oostenbrug LE, Drenth JP, de Jong DJ, et al., Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 567-575.
75. Yang IA, Fong KM, Holgate ST, Holloway JW,. The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol 2006; 6: 23-28.
76. Tsujimoto H, Ono S, Efron PA, et al., Role of Toll-like receptors in the development of sepsis. Shock 2008; 29: 315-321.
77. Mullick AE, Tobias PS, Curtiss LK,. Toll-like receptors and atherosclerosis: key contributors in disease and health? Immunol Res 2006; 34: 193-209.
78. O'Neill LA, Kaltschmidt C,. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997; 20: 252-258.
79. Lee M,. Neurotransmitters and microglial-mediated neuroinflammation. Curr Protein Pept Sci 2013; 14: 21-32.
80. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA,. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 2001; 7: 1291-1297.
81. Lawrence T,. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1: a001651.
82. Pietrobon D,. Calcium channels and migraine. Biochim Biophys Acta 2013; 1828: 1655-1665.
83. Franceschini A, Hullugundi SK, van den Maagdenberg AM, et al., Effects of LPS on P2X3 receptors of trigeminal sensory neurons and macrophages from mice expressing the R192Q Cacna1a gene mutation of familial hemiplegic migraine-1. Purinergic Signal 2013; 9: 7-13.
84. Rautajoki KJ, Kylaniemi MK, Raghav SK, et al., An insight into molecular mechanisms of human T helper cell differentiation. Ann Med 2008; 40: 322-335.
85. Kaiko GE, Horvat JC, Beagley KW, Hansbro PM,. Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 2008; 123: 326-338.
86. Chen CN, Chang SF, Lee PL, et al., Neutrophils, lymphocytes, and monocytes exhibit diverse behaviors in transendothelial and subendothelial migrations under coculture with smooth muscle cells in disturbed flow. Blood 2006; 107: 1933-1942.
87. Scherer DC, Brockman JA, Chen Z, et al., Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A 1995; 92: 11259-11263.
88. Heyninck K, Beyaert R,. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett 1999; 442: 147-150.